FULL PAPER
One-pot Synthesis of 2,4-Diamino-substituted
Li, Xiaoyinga(李肖T颖h) ieno[3,2-d]pyrimidines
Zhang, Yangmingb(张仰明)
Tang, Jiea(汤杰)
Yang, Fan*,a(杨帆)
Nan, Fajun*,b(南发俊)
a Department of Chemistry and Institute of Medicinal Chemistry, East China Normal University,
3663 North Zhong Shan Road, Shanghai 200062, China
b The National Center for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences,
189 Guoshoujing Road, Shanghai 201203, China
An efficient one-pot synthetic approach to 2,4-diamino-substituted thieno[3,2-d]pyrimidines from
2,4-dichlorothieno[3,2-d]pyrimidine was described.
Keywords privileged structure, 2,4-dichlorothieno[3,2-d]pyrimidine, one-pot
Introduction
our previous work, we have reported that the two chlo-
rine atoms in 2- and 4-position showed different reac-
tivity and chloride at 4-position can be removed under
mild hydrogenation condition in the presence of
NaHCO3.5 Considering this reactivity difference of the
two chlorine atoms, we propose that various organic
amines will attack these two chlorine atoms sequentially,
therefore, introduction of two different amino groups in
a one-pot way would be feasible. To our delight, this
approach turned out to be a good alternative method to
As an ideal source for lead discovery, privileged
structures refer to a single molecular framework that is
able to provide ligands for diverse receptors. Since it
was first addressed by Evans et al. in 1988,1 many
skeletons have been identified as privileged structures
and this concept has attracted much attention of me-
dicinal chemists. Nowadays, the construction of com-
pounds libraries based on privileged structures followed
by diverse screening has evolved into a practical strat-
egy to obtain lead compounds with more efficiency.
Thienopyrimidine skeletons are typical privileged
structures with occurrence in a variety of biological ac-
tive compounds. For example, some 2-alkoxy or 2-
alkyl-subsituted thienopyrimidinones show significant
antifungal and antibacterial activities.2a-2d Modification
on 5- and 6-position of thienopyrimidine has led to a
series of N,N-diaryl ureas which potently inhibit both
vascular-growth factor (VEGF) and platelet-derived
growth factor (PDGF) receptor tyrosine kinases.3 As a
continuous work to our previous synthetic methodology
study on selective dechlorination of 2,4-dichloropyrimi-
dines, we intend to develop an efficient synthetic ap-
proach to introduce diverse functional groups through
selective nucleophilic substitution of the chlorine at 2-
and 4-position, so as to explore their chemical space.
Our preliminary study results are described here.
2,4-diamino-substituted
thieno[3,2-d]pyrimidines,
which is much more efficient than traditional stepwise
manner, which requires chromatographic purification
upon each reaction step (Scheme 1).
Scheme
1
One-pot synthesis of 2,4-diamino-substitued
thieno[3,2-d]pyrimidines
In a typical procedure, 2,4-dichlorothieno[3,2-d]-
pyrimidine was dissolved in a suitable aprotic solvent
[dimethylsulphoxide (DMSO), N-methyl-2-pyrrolidine
(NMP) or N,N-dimethylformamide (DMF)]. To this
solution, arylamines (1.5 equiv.) and NaHCO3 (2 equiv.)
were added and the mixture was heated to 100 ℃. It
usually took 3— 4 h to complete the replacement of
4-chlorine atom. Then, without intermediate separation,
a variety of aliphatic amines (5— 10 equiv.) was added
directly and the mixture was heated again to 100 ℃ for
In our research, 2,4-dichlorothieno[3,2-d]pyrimidine
was chosen since it was readily prepared by literature
method as starting material for 2,4-disubstitued thieno-
[3,2-d]pyrimidine. Traditionally 2,4-disubstitued thieno-
[3,2-d]pyrimidines were prepared in a stepwise way.4 In
*
E-mail: yfan@chem.ecnu.edu.cn, fjnan@mail.shcnc.ac.cn; Tel./Fax: 0086-021-62232100, 0086-021-50800954
Received February 22, 2010; revised March 17, 2010; accepted April 20, 2010.
Project supported by the National Natural Science Foundation of China (No. 30725049) and the National Science & Technology Major Project Key
New Drug Creation and Manufacturing Program (No. 2009ZX 09302-001).
Chin. J. Chem. 2010, 28, 1437— 1440
© 2010 SIOC, CAS, Shanghai, & WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
1437